{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:38:39Z","timestamp":1792571919851,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chirurgie"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00104-026-02580-4","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:47:34Z","timestamp":1789562854000},"page":"874-879","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Isolierte Extremit\u00e4tenperfusion zur Vermeidung von mutilierenden Resektionen","Isolated limb perfusion to avoid mutilating surgical resections"],"prefix":"10.1007","volume":"97","author":[{"given":"Madelaine","family":"Hettler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Ulf","family":"Tunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,16]]},"reference":[{"issue":"5","key":"2580_CR1","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.ejso.2022.12.002","volume":"49","author":"L Conti","year":"2023","unstructured":"Conti\u00a0L, Buriro\u00a0F, Baia\u00a0M et\u00a0al (2023) Contemporary role of amputation for patients with extremity soft tissue sarcoma. Eur J Surg Oncol 49(5):934\u2013940. https:\/\/doi.org\/10.1016\/j.ejso.2022.12.002","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"2580_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1245\/s10434-017-5895-2","volume":"25","author":"HG Smith","year":"2018","unstructured":"Smith\u00a0HG, Thomas\u00a0JM, Smith\u00a0MJF, Hayes\u00a0AJ, Strauss\u00a0DC (2018) Major Amputations for Extremity Soft-Tissue Sarcoma. Ann Surg Oncol 25(2):387\u2013393. https:\/\/doi.org\/10.1245\/s10434-017-5895-2","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"2580_CR3","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.ejso.2021.08.007","volume":"48","author":"SJM Reijers","year":"2022","unstructured":"Reijers\u00a0SJM, Husson\u00a0O, Soomers\u00a0VLMN et\u00a0al (2022) Health-related quality of life after isolated limb perfusion compared to extended resection, or amputation for locally advanced extremity sarcoma: Is a limb salvage strategy worth the effort? Eur J Surg Oncol 48(3):500\u2013507. https:\/\/doi.org\/10.1016\/j.ejso.2021.08.007","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"2580_CR4","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1007\/s001040050132","volume":"67","author":"M Schwarzbach","year":"1996","unstructured":"Schwarzbach\u00a0M, Lehnert\u00a0T, Willeke\u00a0F, Hinz\u00a0U, Herfarth\u00a0C (1996) Ergebnisse der isolierten hyperthermen Extremit\u00e4tenperfusion bei Weichteilsarkomen im Rahmen eines multimodalen Behandlungskonzeptes. Chirurgie 67(12):1237\u20131243. https:\/\/doi.org\/10.1007\/s001040050132 (The results of isolated hyperthermic limb perfusion in a\u00a0multimodality therapy concept for soft-tissue sarcoma)","journal-title":"Der Chirurg"},{"issue":"4","key":"2580_CR5","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/00000658-195810000-00009","volume":"148","author":"O Creech","year":"1958","unstructured":"Creech\u00a0O, Krementz\u00a0ET, Ryan\u00a0RF, Winblad\u00a0JN (1958) Chemotherapy of Cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148(4):616\u2013632. https:\/\/doi.org\/10.1097\/00000658-195810000-00009","journal-title":"Ann Surg"},{"key":"2580_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.112949","volume":"190","author":"SJM Reijers","year":"2023","unstructured":"Reijers\u00a0SJM, Davies\u00a0E, Gr\u00fcnhagen\u00a0DJ et\u00a0al (2023) Variation in response rates to isolated limb perfusion in different soft-tissue tumour subtypes: an international multi-centre study. Eur J Cancer 190:112949. https:\/\/doi.org\/10.1016\/j.ejca.2023.112949","journal-title":"Eur J Cancer"},{"key":"2580_CR7","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2022) S3-Leitlinie Adulte Weichgewebesarkome, Langversion 1.1. https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/adulte-weichgewebesarkome\/ (S3-Leitlinie) (AWMF- Registernummer: 032\/044OL)"},{"key":"2580_CR8","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2020) S3-Leitlinie: Diagnostik, Therapie und Nachsorge des Melanoms, Langversion 3.3. http:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/melanom\/ (AWMF Registernummer: 032\/024OL)"},{"issue":"6","key":"2580_CR9","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1097\/00000658-199612000-00011","volume":"224","author":"AM Eggermont","year":"1996","unstructured":"Eggermont\u00a0AM, Schraffordt Koops\u00a0H, Klausner\u00a0JM et\u00a0al (1996) Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience. Ann Surg 224(6):756\u2013764. https:\/\/doi.org\/10.1097\/00000658-199612000-00011 (discussion 764-5)","journal-title":"Ann Surg"},{"issue":"8","key":"2580_CR10","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1002\/jso.23591","volume":"109","author":"J Jakob","year":"2014","unstructured":"Jakob\u00a0J, Tunn\u00a0PU, Hayes\u00a0AJ, Pilz\u00a0LR, Nowak\u00a0K, Hohenberger\u00a0P (2014) Oncological outcome of primary non-metastatic soft tissue sarcoma treated by neoadjuvant isolated limb perfusion and tumor resection. J\u00a0Surg Oncol 109(8):786\u2013790. https:\/\/doi.org\/10.1002\/jso.23591","journal-title":"J Surg Oncol"},{"issue":"17","key":"2580_CR11","doi-asserted-by":"publisher","first-page":"2624","DOI":"10.1002\/cncr.29991","volume":"122","author":"J Jakob","year":"2016","unstructured":"Jakob\u00a0J, Hohenberger\u00a0P (2016) Role of isolated limb perfusion with recombinant human tumor necrosis factor alpha and melphalan in locally advanced extremity soft tissue sarcoma. Cancer Cytopathol 122(17):2624\u20132632. https:\/\/doi.org\/10.1002\/cncr.29991","journal-title":"Cancer"},{"issue":"30","key":"2580_CR12","doi-asserted-by":"publisher","first-page":"4036","DOI":"10.1200\/JCO.2011.35.6618","volume":"29","author":"JP Deroose","year":"2011","unstructured":"Deroose\u00a0JP, Eggermont\u00a0AM, van Geel\u00a0AN et\u00a0al (2011) Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas. J\u00a0Clin Oncol 29(30):4036\u20134044. https:\/\/doi.org\/10.1200\/JCO.2011.35.6618","journal-title":"J Clin Oncol"},{"issue":"7","key":"2580_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/jso.21885","volume":"103","author":"ML Hoven-Gondrie","year":"2011","unstructured":"Hoven-Gondrie\u00a0ML, Bastiaannet\u00a0E, van Ginkel\u00a0RJ, Suurmeijer\u00a0AJ, Hoekstra\u00a0HJ (2011) TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome. J\u00a0Surg Oncol 103(7):648\u2013655. https:\/\/doi.org\/10.1002\/jso.21885","journal-title":"J Surg Oncol"},{"issue":"2","key":"2580_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/02656736.2015.1109146","volume":"32","author":"D Andreou","year":"2016","unstructured":"Andreou\u00a0D, Werner\u00a0M, Pink\u00a0D et\u00a0al (2016) Histological response assessment following neoadjuvant isolated limb perfusion in patients with primary, localised, high-grade soft tissue sarcoma. Int J Hyperthermia 32(2):159\u2013164. https:\/\/doi.org\/10.3109\/02656736.2015.1109146","journal-title":"Int J Hyperthermia"},{"issue":"4","key":"2580_CR15","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1634\/theoncologist.2009-0325","volume":"15","author":"D Moreno-Ramirez","year":"2010","unstructured":"Moreno-Ramirez\u00a0D, de la Cruz-Merino\u00a0L, Ferrandiz\u00a0L, Villegas-Portero\u00a0R, Nieto-Garcia\u00a0A (2010) Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety. Oncologist 15(4):416\u2013427. https:\/\/doi.org\/10.1634\/theoncologist.2009-0325","journal-title":"Oncologist"},{"key":"2580_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13215485","author":"L Sevilla-Ortega","year":"2021","unstructured":"Sevilla-Ortega\u00a0L, Ferrandiz-Pulido\u00a0L, Palazon-Carrion\u00a0N et\u00a0al (2021) Role of Isolated Limb Perfusion in the Era of Targeted Therapies and Immunotherapy in Melanoma. A Systematic Review of The Literature. Cancers. https:\/\/doi.org\/10.3390\/cancers13215485","journal-title":"Cancers (Basel)"},{"issue":"7","key":"2580_CR17","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1093\/annonc\/mdi229","volume":"16","author":"S Bonvalot","year":"2005","unstructured":"Bonvalot\u00a0S, Laplanche\u00a0A, Lejeune\u00a0F et\u00a0al (2005) Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF\u2011\u03b1 be better? Facts Views Vis Obgyn 16(7):1061\u20131068. https:\/\/doi.org\/10.1093\/annonc\/mdi229","journal-title":"Ann Oncol"},{"issue":"5","key":"2580_CR18","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1054\/bjoc.1999.1032","volume":"82","author":"JHW De Wilt","year":"2000","unstructured":"De Wilt\u00a0JHW, Ten Hagen\u00a0TLM, De Boeck\u00a0G, Van Tiel\u00a0ST, De Bruijn\u00a0EA, Eggermont\u00a0AMM (2000) Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion. Br J Cancer 82(5):1000\u20131003. https:\/\/doi.org\/10.1054\/bjoc.1999.1032","journal-title":"Br J Cancer"},{"issue":"4","key":"2580_CR19","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1038\/nm0498-408","volume":"4","author":"C R\u00fcegg","year":"1998","unstructured":"R\u00fcegg\u00a0C, Yilmaz\u00a0A, Bieler\u00a0G, Bamat\u00a0J, Chaubert\u00a0P, Lejeune\u00a0FJ (1998) Evidence for the involvement of endotheliai cell integrin \u03b1V\u03b23 in the disruption of the tumor vascuiature induced by TNF and IFN\u2011\u03b3. Nat Med 4(4):408\u2013414. https:\/\/doi.org\/10.1038\/nm0498-408","journal-title":"Nat Med"},{"issue":"6","key":"2580_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108050","volume":"50","author":"AJ Hayes","year":"2024","unstructured":"Hayes\u00a0AJ, Coker\u00a0DJ, Been\u00a0L et\u00a0al (2024) Technical considerations for isolated limb perfusion: A consensus paper. Eur J Surg Oncol 50(6):108050. https:\/\/doi.org\/10.1016\/j.ejso.2024.108050","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"2580_CR21","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1097\/CORR.0000000000003584","volume":"483","author":"J Lesensky","year":"2025","unstructured":"Lesensky\u00a0J, Blecha\u00a0O, Belzarena\u00a0AC, Vocka\u00a0M, Spacek\u00a0M (2025) Isolated Limb Perfusion Can Avert Amputation Indication in Initially Nonsalvageable Sarcomas of the Extremities. Clin Orthop Relat Res 483(9):1667\u20131676. https:\/\/doi.org\/10.1097\/CORR.0000000000003584","journal-title":"Clin Orthop Relat Res"},{"issue":"10","key":"2580_CR22","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","volume":"18","author":"J Wieberdink","year":"1982","unstructured":"Wieberdink\u00a0J, Benckhuysen\u00a0C, Braat\u00a0RP, van Slooten\u00a0EA, Olthuis\u00a0GA (1982) Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. Eur J Cancer Clin Oncol 18(10):905\u2013910. https:\/\/doi.org\/10.1016\/0277-5379(82)90235-8","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"3","key":"2580_CR23","doi-asserted-by":"publisher","first-page":"237","DOI":"10.6061\/clinics\/2012(03)06","volume":"67","author":"JP Duprat Neto","year":"2012","unstructured":"Duprat Neto\u00a0JP, Oliveira\u00a0F, Bertolli\u00a0E et\u00a0al (2012) Isolated limb perfusion with hyperthermia and chemotherapy: predictive factors for regional toxicity. Clinics (Sao Paulo) 67(3):237\u2013241. https:\/\/doi.org\/10.6061\/clinics\/2012(03)06","journal-title":"Clinics (Sao Paulo)"},{"issue":"11","key":"2580_CR24","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1016\/j.ejso.2020.06.040","volume":"46","author":"TJ Kenyon-Smith","year":"2020","unstructured":"Kenyon-Smith\u00a0TJ, Kroon\u00a0HM, Miura\u00a0JT et\u00a0al (2020) Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre study. Eur J Surg Oncol 46(11):2140\u20132146. https:\/\/doi.org\/10.1016\/j.ejso.2020.06.040","journal-title":"Eur J Surg Oncol"},{"issue":"6","key":"2580_CR25","first-page":"681","volume":"20","author":"BC Vrouenraets","year":"1994","unstructured":"Vrouenraets\u00a0BC, Eggermont\u00a0AM, Klaase\u00a0JM, Van Geel\u00a0BN, Van Dongen\u00a0JA, Kroon\u00a0BB (1994) Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbs. Eur J Surg Oncol 20(6):681\u2013685","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"2580_CR26","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/0277-5379(82)90235-8","volume":"18","author":"J Wieberdink","year":"1982","unstructured":"Wieberdink\u00a0J, Benckhuysen\u00a0C, Braat\u00a0RP, Van Slooten\u00a0EA, Olthuis\u00a0GAA (1982) Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions. European Journal of Cancer and Clinical Oncology 18(10):905\u2013910. https:\/\/doi.org\/10.1016\/0277-5379(82)90235-8","journal-title":"European Journal of Cancer and Clinical Oncology"},{"key":"2580_CR27","series-title":"Springer Reference Medizin","volume-title":"Kompendium Internistische Onkologie","author":"J Jakob","year":"2025","unstructured":"Jakob\u00a0J, Hettler\u00a0M (2025) Extremit\u00e4tenperfusion beim Weichgewebssarkom und malignen Melanom. In: Schmoll\u00a0HJ (Hrsg) Kompendium Internistische Onkologie. Springer Reference Medizin. Springer, Berlin, Heidelberg"}],"container-title":["Die Chirurgie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-026-02580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-026-02580-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00104-026-02580-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:44:32Z","timestamp":1792568672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00104-026-02580-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,16]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["2580"],"URL":"https:\/\/doi.org\/10.1007\/s00104-026-02580-4","relation":{},"ISSN":["2731-6971","2731-698X"],"issn-type":[{"value":"2731-6971","type":"print"},{"value":"2731-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,16]]},"assertion":[{"value":"10 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.\u00a0Hettler und P.-U.\u00a0Tunn geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}